Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Janssens (Antwerp, Belgium), K. Lamote (Antwerp, Belgium), J. Van Meerbeeck (Antwerp, Belgium), L. Brusselmans (Antwerp, Belgium). Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.. 1759

Member's Comments

No comment yet.

Related content which might interest you: Breath analysis by ion mobility spectrometry in COPD and lung cancer patients Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Ion mobility spectrometry in lung transplant patients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Breath analysis by ion mobility spectrometry in sarcoidosis – results of a feasibility study Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Detection of lung cancer using ion mobility spectrometry in Japan: A pilot study Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Detection of pseudomonas aeruginosa (Pa) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011